Alert as MFDA discovers fake cancer drug in market

Aug 13, 2026, 8:18 AM
Counterfeit injections prepared to look like the original product are being imported and sold in the Maldives. -- Photo: MedPage Today

Counterfeit injections prepared to look like the original product are being imported and sold in the Maldives. -- Photo: MedPage Today

The Maldives Food and Drug Authority (MFDA) has confirmed that a counterfeit version of an injectable cancer medication is being imported and sold in the Maldives.

In an alert issued yesterday, the authority identified the counterfeit product as Opdivo (Nivolumab) 10mg/10ml, batch number 8081399.

The MFDA has strictly prohibited the import, sale, and use of this batch of Nivolumab within the country.

This follows a previous health alert issued in May, when the authority published a list of 21 medications being illegally imported and sold by unauthorized parties.

At that time, the MFDA noted that unauthorized individuals were importing medicines and selling them through online platforms and general retail shops.

Under national regulations, medicines can only be imported into the Maldives by entities registered as authorized importers with the MFDA. Furthermore, all imported medications must be registered in accordance with established guidelines and included on the country's approved drug list.

Comments

Read More

Latest News

Scholars urge government to halt Eagle Hills Rasmalé project

The Scholars’ Union of the Maldives is urging the government to halt the $12 billion Ras Malé project with Eagle Hills. The group claims the deal violates Islamic law and the constitution by potentially allowing non-Muslims to settle permanently. They warn the project could cause irreversible harm to the nation’s religious identity.

Parliament advances Real Estate Bill

The Maldives parliament advanced a bill allowing foreign property buyers to renew 99-year leases indefinitely. By issuing a new lease upon each resale, the law bypasses constitutional limits to boost the real estate market. The bill also formalizes a $12 billion deal with a developer for the Ras Malé project.

Government signs third deal for Ihavandhippolhu

The Maldives government signed a third agreement for the Ihavandhippolhu project, this time with Abu Dhabi’s SAH Group. The deal covers a commercial port and tourism infrastructure for the Maldives Economic Gateway. This follows two previous agreements with foreign firms that have yet to result in any physical work on the site.

Next year’s budget plans no hiring for new posts: Finance

The Maldives finance ministry announced that next year's budget includes no hiring for new positions to ensure economic sustainability. Officials stated that current salaries align with state revenue and that a 10% cap on overtime pay was necessary to prevent debt. No base salaries will be cut under the new pay harmonization framework.

Defamation bill aims to hide government corruption: Fittey

MP Hussain Ziyad criticized a proposed defamation bill, claiming its true purpose is to shield government corruption from public scrutiny. He warned that the bill's vague language and heavy fines, ranging up to MVR 500,000, threaten free speech. Ziyad argued the law mirrors past efforts to suppress reports on government misconduct.

Pension office dismisses COO Shiuna

The Maldives Pension Administration Office dismissed COO Mariyam Shiuna following her suspension in September. Shiuna was reportedly ousted after raising concerns about the chairperson and opposing a government plan to print money through the office. She previously led the Anti-Corruption Commission before joining the agency in 2023.

Defamation bill aims to stifle criticism of Rasmalé deal: Mauroof

MP Mauroof Zakir claims a new defamation bill aims to silence criticism of the Ras Male project and government accountability. The legislation proposes heavy fines and jail time for statements, gestures, or art deemed defamatory. Mauroof argues the bill is a tool to hide corruption and financial mismanagement from public scrutiny.

Newsletter

Get the latest news delivered straight to your inbox